Growth Equity

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

With a successful $191M IPO, Alamar Biosciences is set to revolutionize diagnostics with its ultra-sensitive proteomics platforms.

BTG Pactual TIG is funneling billions into Latin American timber, blending high finance with ambitious climate and biodiversity goals. What's behind this green gold rush?

Deep-tech firm AHOY surpasses $100M ARR with its "Real-World AI," now seeking major funding to expand its sovereign AI for critical infrastructure.

Tech-driven supply platform Odeko acquires a 37-year-old Boston distributor and enters Nashville, signaling a major shift for independent cafes.

With founder Frédéric Mascha as Executive Chairman and new CEO Renaud Sermondade, Juvisé Pharmaceuticals is poised for major M&A-fueled global expansion.

A luxury brand and an NGO award women in bio-tech and MedTech, tackling the stark funding gap and championing a new generation of impact-driven founders.

Hospitality platform Listo is rapidly expanding into the nation's top venues, using its software to cut costs and perfect the fan experience behind the scenes.

Win a VIP trip to meet P!NK while supporting vital cancer research. A new fundraising model emerges as public funding for life-saving science dwindles.

Orum Therapeutics adds deep clinical and dealmaking expertise to its board, signaling a strategic acceleration of its innovative DAC pipeline for cancer.

Cleaning solutions giant Zep appoints turnaround specialist Tim Feast as CEO, signaling a new era of growth under private equity owner Truelink Capital.

Software pioneer Horizon Quantum acquires a powerful 256-qubit IonQ computer, a key step in creating a universal platform for quantum developers.

Transom Capital Group appoints Luke Dauch, a decade-long J.P. Morgan banker, to bolster its deal origination in a competitive middle-market landscape.

With a new MD and key promotions, the firm signals a strategic push to deepen its human capital and investor relations for its next growth phase.

With $10M, Livid offers Vimeo users an escape from Bending Spoons' playbook of price hikes, backed by a free one-click video migration tool.

EDERRA's new partnership with Cepham signals a shift in wellness, blending brand transparency with manufacturing science to lead the functional food market.

Crux Capital's new partnership with Ivybrook Academy signals a major investment trend in flexible, high-quality early education franchise models.

A biotech firm is putting genetically engineered probiotics on bar menus. Is this the future of nightlife or a high-tech placebo for the mindful drinker?

A new partnership combines clinical care with logistical support, aiming to solve the caregiving puzzle for employers and their increasingly stressed employees.